Clinical Trial Update: Spinal Cord Injury Neuroprotection With Glyburide [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating glyburide for neuroprotection in acute spinal cord injury; terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Glyburide (glyburide)

Snippet

Sponsor: Ohio State University | Conditions: Acute Spinal Cord Injury | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2022-06-07